ECOR1 CAPITAL
EcoR1 Capital is a biotech-focused investment advisory firm.
ECOR1 CAPITAL
Social Links:
Industry:
Biotechnology Financial Services
Founded:
2012-01-01
Status:
Active
Contact:
415-754-3517
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Content Delivery Network Google Universal Analytics
Similar Organizations
BioMedPartners
BioMedPartners is one of the leading European venture capital firms.
gumi Cryptos Capital (gCC)
gumi Cryptos Capital is a blockchain and cryptographic asset venture fund
Logos Capital
Logos Capital is a fundamental biotechnology-focused investment fund.
LYFE Capital
LYFE Capital is a life science investment firm.
Polaris Partners
Polaris Partners is an investment firm that invests in healthcare and biotechnology companies.
RA Capital Management
RA Capital Management is an investment advisor specializing in the life-sciences and drug development sectors.
Refactor Capital
Refactor Capital is a seed stage VC firm investing in bio, climate, and health.
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-09-07 | SpringWorks Therapeutics | EcoR1 Capital investment in Post-IPO Equity - SpringWorks Therapeutics | 225 M USD |
| 2022-08-25 | Aktis Oncology | EcoR1 Capital investment in Series A - Aktis Oncology | 84 M USD |
| 2022-08-19 | Kymera Therapeutics | EcoR1 Capital investment in Post-IPO Equity - Kymera Therapeutics | 150 M USD |
| 2022-07-27 | AlloVir | EcoR1 Capital investment in Post-IPO Equity - AlloVir | 126.6 M USD |
| 2022-07-13 | Gossamer Bio | EcoR1 Capital investment in Post-IPO Equity - Gossamer Bio | 120 M USD |
| 2022-04-27 | Tempest Therapeutics | EcoR1 Capital investment in Post-IPO Equity - Tempest Therapeutics | 15 M USD |
| 2022-03-16 | 2seventy bio | EcoR1 Capital investment in Post-IPO Equity - 2seventy bio | 170 M USD |
| 2022-02-03 | Dewpoint Therapeutics | EcoR1 Capital investment in Series C - Dewpoint Therapeutics | 150 M USD |
| 2022-01-06 | Eikon Therapeutics | EcoR1 Capital investment in Series B - Eikon Therapeutics | 518 M USD |
| 2021-12-27 | Pardes Biosciences | EcoR1 Capital investment in Post-IPO Equity - Pardes Biosciences | 75 M USD |
More informations about "EcoR1 Capital"
EcoR1 Capital - Crunchbase Investor Profile
EcoR1 Capital is an investment advisory firm focused on the biotech industry. They aim to identify and evaluate innovative therapeutic solutions that can bring significant improvements to patients' lives. Drawing inspiration from the …See details»
ECOR1 CAPITAL, LLC Top 13F Holdings - WhaleWisdom.com
Ecor1 Capital is a hedge fund with 5 clients and discretionary assets under management (AUM) of $5,001,741,440 (Form ADV from 2024-10-18). Their last reported 13F filing for Q1 2025 …See details»
Ecor1 Capital – Fund and Executive Details - Private Fund Data
Ecor1 Capital is a hedge fund company based in San Francisco, CA. They operate 3 private funds and have approximately $573.8 million in total assets under management (AUM). You can …See details»
ECOR1 CAPITAL, LLC | Form ADV - Radient
Mar 31, 2025 EcoR1 Capital, LLC is a limited liability company founded in 2012 with Oleg Nodelman as the manager, controlling owner, and portfolio manager. As of December 31, …See details»
EcoR1 Capital - The Org
EcoR1 Capital is a biotech-focused investment advisory firm established in 2013, which invests in companies at all stages of research and development. Industries. Investment Management. …See details»
ECOR1 CAPITAL, LLC - Hedge Fund Database
EcoR1 currently serves as the general partner and investment adviser to its main funds, which make a variety of investments following the investment strategy described herein. EcoR1 has …See details»
Hedge Fund - EcoR1 Capital - Insider Monkey
EcoR1 Capital is a hedge fund managing discretionary assets totaling $5,001,741,440 for 5 clients, as reported in their Form ADV on March 28, 2024. Their most recent 13F filing for Q1 …See details»
EcoR1 Capital, LLC - 13F
EcoR1 Capital, LLC reported 46 holdings with total value $1.69 B as of Q1 2025. Top holdings included APLS, JAZZ, ZYME, ANAB, and CRNX. EcoR1 Capital, LLC 13F Portfolio Filings …See details»
About | EcoR1 Capital
Like the EcoR1 restriction enzyme which transformed the biomedical field, we help move medical research forward by investing in compelling biotech companies that develop promising new solutions for untreated diseases. None …See details»
EcoR1 Capital Portfolio | Oleg Nodelman 13F Holdings & Trades
EcoR1 Capital: Oleg Nodelman-13.48%: $2496418000: 55: Top Holdings Largest Trades Portfolio Structure Sector Allocation Performance History. EcoR1 Capital Holdings Map. Stock Holdings …See details»
EcoR1 Capital - Investments, Portfolio & Company Exits
EcoR1 Capital 's most notable exits include Nurix Therapeutics, ... Which industries has this organization had the most exits in? Show . Nurix Therapeutics Nurix Therapeutics is a …See details»
Diving into a Detailed History: EcoR1 Capital, LLC's Quarterly 13F ...
EcoR1 Capital, LLC 13F Filings; EcoR1 Capital, LLC Notable People: Oleg Nodelman, Ivan Gaviria, Peter Svennilson. Fund Profile & Top 10 Positions; All 13Fs; AUM 3.95B ; CAGR in …See details»
What’s Behind EcoR1’s Healthy Returns | Institutional Investor
Jan 21, 2022 EcoR1 Capital has once again posted strong results.The life sciences fund headed by Oleg Nodelman was up 29 percent last year, according to an investor.This is especially …See details»
EcoR1 Capital - Leadership Team - The Org
The Leadership Team at EcoR1 Capital is responsible for setting the strategic direction of the firm and overseeing its investment operations within the biotech sector. This team, composed of …See details»
Team | EcoR1 Capital
EcoR1 Capital, LLC 357 Tehama Street, Floor 3 San Francisco, CA 94103See details»
EcoR1 Capital Fund Performance History & Annualized Return
EcoR1 Capital: Oleg Nodelman-27.02%: $1681798000: 44: Top Holdings Largest Trades Portfolio Structure Sector Allocation Performance History. EcoR1 Capital Holdings Map. Stock Holdings …See details»
Portfolio | EcoR1 Capital
There can be no assurance that the investments referenced were, are, or will be, profitable. This is for information purposes only and should not be construed as an investment …See details»
Oleg Nodelman - Founder & Managing Director @ EcoR1 Capital ...
Oleg Nodelman is the Founder and Managing Director of EcoR1 Capital LLC, a biotech-focused investment advisory firm established in 2013, which invests in companies at all stages of …See details»
National Angel Capital Organization (NACO) Unveils Canada's 'Top …
4 days ago Toronto, ON, May 20, 2025--(T-Net)--The National Angel Capital Organization (NACO) has unveiled Canada's Top 20 Moonshot Ventures of 2025—emerging companies led …See details»
EcoR1 Capital - Funding, Financials, Valuation & Investors
EcoR1 Capital has raised 4 funds, their latest being EcoR1 Venture Opportunity Fund, LP. This fund was announced on Oct 9, 2019 and raised a total of . obfuscated. obfuscated. …See details»